Scholarlink

Background <p>Periodontitis affects over 1&#xa0;billion people globally, with oxidative stress and glutathione depletion playing crucial roles in disease progression. This study aimed to identify glutathione metabolism-related genes as diagnostic biomarkers for periodontitis using integrated bioinformatics approaches.</p> Methods <p>Weighted Gene Co-expression Network Analysis (WGCNA) was performed on independent datasets. Key genes were identified in combination with GSE16134 dataset differential expression analysis, which were then validated in the GSE10334 dataset. Immune infiltration analysis using CIBERSORT algorithm, consensus clustering for molecular subtyping, and competing endogenous RNA (ceRNA) network construction were conducted to explore regulatory mechanisms. Drug-gene interaction analysis and molecular docking studies identified potential therapeutic compounds. Experimental validation was performed using ligature-induced periodontitis in rats.</p> Results <p>Three key glutathione metabolism-related genes were identified: GSTA4 and GGT6 (downregulated) and SLC7A11 (upregulated) in periodontitis patients. The diagnostic model achieved superior performance with AUC values exceeding 0.8. Two distinct molecular subtypes were identified based on immune infiltration patterns. ceRNA regulatory network analysis revealed complex interactions involving all three genes. Drug-gene interaction analysis revealed erastin as a potential therapeutic compound targeting SLC7A11. Experimental validation in rat periodontitis confirmed the upregulation of SLC7A11 in periodontal tissues.</p> Conclusions <p>Our study identifies SLC7A11, GSTA4, and GGT6 as robust periodontitis biomarkers with excellent diagnostic accuracy. The continuous up-regulation and experimental verification of SLC7A11 genes have established them as promising therapeutic targets, laying the foundation for precision medicine in the field of periodontal therapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrated bioinformatics analysis identifies glutathione metabolism-related genes as diagnostic biomarkers for periodontitis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月6日

查看全文
  • Leilei Meng,
  • Haoshu Fang,
  • Wenjie Wen

摘要

Background

Periodontitis affects over 1 billion people globally, with oxidative stress and glutathione depletion playing crucial roles in disease progression. This study aimed to identify glutathione metabolism-related genes as diagnostic biomarkers for periodontitis using integrated bioinformatics approaches.

Methods

Weighted Gene Co-expression Network Analysis (WGCNA) was performed on independent datasets. Key genes were identified in combination with GSE16134 dataset differential expression analysis, which were then validated in the GSE10334 dataset. Immune infiltration analysis using CIBERSORT algorithm, consensus clustering for molecular subtyping, and competing endogenous RNA (ceRNA) network construction were conducted to explore regulatory mechanisms. Drug-gene interaction analysis and molecular docking studies identified potential therapeutic compounds. Experimental validation was performed using ligature-induced periodontitis in rats.

Results

Three key glutathione metabolism-related genes were identified: GSTA4 and GGT6 (downregulated) and SLC7A11 (upregulated) in periodontitis patients. The diagnostic model achieved superior performance with AUC values exceeding 0.8. Two distinct molecular subtypes were identified based on immune infiltration patterns. ceRNA regulatory network analysis revealed complex interactions involving all three genes. Drug-gene interaction analysis revealed erastin as a potential therapeutic compound targeting SLC7A11. Experimental validation in rat periodontitis confirmed the upregulation of SLC7A11 in periodontal tissues.

Conclusions

Our study identifies SLC7A11, GSTA4, and GGT6 as robust periodontitis biomarkers with excellent diagnostic accuracy. The continuous up-regulation and experimental verification of SLC7A11 genes have established them as promising therapeutic targets, laying the foundation for precision medicine in the field of periodontal therapy.